Brain Cancer
Brain Cancer: Public Health and Genomic Insights - June 1, 2015
NCI information: Genetic susceptibility and brain tumors
Risk factors for brain and spinal cord tumors include genetics and family history, from the American Cancer Society
from the American Cancer SocietyCheck out genes reported with risk and outcomes of brain cancers, from the HuGE Navigator
from the HuGE NavigatorEpidemiology and diagnosis of brain tumors.
Butowski NA et al. Continuum (Minneap Minn) 2015 Apr (2 Neuro-oncology) 301-13
Butowski NA et al. Continuum (Minneap Minn) 2015 Apr (2 Neuro-oncology) 301-13
The emerging molecular foundations of pediatric brain tumors.
Huse JT et al. J. Child Neurol. 2015 Apr 14.
Huse JT et al. J. Child Neurol. 2015 Apr 14.
Brain tumor mutations detected in cerebral spinal fluid.
Pan W et al. Clin. Chem. 2015 Mar (3) 514-22
Pan W et al. Clin. Chem. 2015 Mar (3) 514-22
Germline mutations in shelterin complex genes are associated with familial glioma.
Bainbridge MN et al. J. Natl. Cancer Inst. 2015 Jan (1) 384
Bainbridge MN et al. J. Natl. Cancer Inst. 2015 Jan (1) 384
Epidemiology of gliomas.
Ostrom QT et al. Cancer Treat. Res. 2015 1-14
Ostrom QT et al. Cancer Treat. Res. 2015 1-14
Risk score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J et al. Carcinogenesis 2014 Dec (12) 2756-62
Sana J et al. Carcinogenesis 2014 Dec (12) 2756-62
Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
Bastien JI et al. Cancer 2015 Feb 15. (4) 502-16
Bastien JI et al. Cancer 2015 Feb 15. (4) 502-16
Central nervous system germ cell tumors: an update.
Dufour C et al. Curr Opin Oncol 2014 Nov (6) 622-6
Dufour C et al. Curr Opin Oncol 2014 Nov (6) 622-6
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma.
Jones C et al. Nat. Rev. Cancer 2014 Oct (10)
Jones C et al. Nat. Rev. Cancer 2014 Oct (10)
Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activation.
Furgason JM et al. Mutagenesis 2014 Sep (5) 341-50
Furgason JM et al. Mutagenesis 2014 Sep (5) 341-50
Genomic landscape of glioblastoma and the potential clinical utility.
Wang CJ et al. CNS Oncol 2014 May (3) 169-72
Wang CJ et al. CNS Oncol 2014 May (3) 169-72
Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
Grant R et al. CNS Oncol 2014 Mar (2) 123-36
Grant R et al. CNS Oncol 2014 Mar (2) 123-36
The molecular landscape of pediatric brain tumors in the next-generation sequencing era.
Firme MR et al. Curr Neurol Neurosci Rep 2014 Sep (9) 474
Firme MR et al. Curr Neurol Neurosci Rep 2014 Sep (9) 474
Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective.
Tsankova NM et al. J. Neurooncol. 2014 Sep (3) 481-90
Tsankova NM et al. J. Neurooncol. 2014 Sep (3) 481-90
Gene therapy shows early promise against deadly brain cancer, by Alan Mozes, HealthDay, Mayo Clinic, May 31
by Alan Mozes, HealthDay, Mayo Clinic, May 31
.png)
No hay comentarios:
Publicar un comentario